These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 2549528
1. Relaxant effects of the selective phosphodiesterase inhibitors milrinone and OPC 3911 on isolated human mesenteric vessels. Lindgren S, Andersson KE, Belfrage P, Degerman E, Manganiello VC. Pharmacol Toxicol; 1989 May; 64(5):440-5. PubMed ID: 2549528 [Abstract] [Full Text] [Related]
5. Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and rat. Lindgren S, Andersson KE. Acta Physiol Scand; 1991 May; 142(1):77-82. PubMed ID: 1652182 [Abstract] [Full Text] [Related]
10. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Delpy E, Coste H, Gouville AC. Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166 [Abstract] [Full Text] [Related]
11. Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries. He GW, Yang CO, Gately H, Furnary A, Swanson J, Ahmad A, Floten S, Wood J, Starr A. Br J Clin Pharmacol; 1996 Feb; 41(2):101-7. PubMed ID: 8838435 [Abstract] [Full Text] [Related]
12. The vasorelaxant effects of milrinone and other vasodilators are attenuated by ouabain. Harris AL, Silver PJ, Lemp BM, Evans DB. Eur J Pharmacol; 1988 Jan 12; 145(2):133-9. PubMed ID: 2832186 [Abstract] [Full Text] [Related]
13. Relaxation induced by milrinone and rolipram in human penile arteries and veins. Segarra G, Medina P, Vila JM, Martinez-León JB, Domenech C, Prieto F, Lluch S. Eur J Pharmacol; 2002 May 24; 444(1-2):103-6. PubMed ID: 12191588 [Abstract] [Full Text] [Related]
19. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC. Biochem Pharmacol; 1987 Nov 15; 36(22):3965-72. PubMed ID: 2825708 [Abstract] [Full Text] [Related]
20. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations. von der Leyen H, Mende U, Meyer W, Neumann J, Nose M, Schmitz W, Scholz H, Starbatty J, Stein B, Wenzlaff H. Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul 15; 344(1):90-100. PubMed ID: 1723153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]